Viamet Reports Additional Positive Interim Results of Phase 2 Studies of VT-1161 in Patients with Moderate to Severe Interdigital Tinea Pedis

Study Demonstrated Strong Evidence of Clinical Antifungal Activity and a Favorable Safety Profile. Phase 2b Trial Planned for Onychomycosis in the Fourth Quarter of 2014... [more]

View complete Press Release article